The azithromycin to prevent wheezing following severe RSV bronchiolitis-II clinical trial: Rationale, study design, methods, and characteristics of study population.
Contemp Clin Trials Commun
; 22: 100798, 2021 Jun.
Article
em En
| MEDLINE
| ID: mdl-34189338
AE, Adverse events; AESI, AEs of Special Interest; APW, Azithromycin to Prevent Wheezing; AZM, Azithromycin; Asthma; Azithromycin; DSMB, Data safety and monitoring board; ED, Emergency department; ICS, Inhaled corticosteroids; IL, Interleukin; IRB, Institutional review board; LRTI, Lower respiratory tract infection; MMP-9, Matrix metallopeptidase-9; Microbiome; NHLBI, National Heart, Lung, and Blood Institute; PC, Phone call; RBEL, RSV Bronchiolitis in Early Life; RSV, Respiratory syncytial virus; RW, Recurrent wheezing; RZ, Randomization; Recurrent wheezing; Respiratory syncytial virus (RSV) bronchiolitis; SAE, serious adverse events; SLCH, Saint Louis Children's Hospital; V, visit
Texto completo:
1
Bases de dados:
MEDLINE
Tipo de estudo:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Contemp Clin Trials Commun
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Estados Unidos